ALB · Albemarle Corp
$137.36
+1.59 (+1.17%)
At close · Aug 28
Market Cap
$16.21B
Shares
118.01M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$137.36
Open$138.75
Day$135.73–141.22
52W close$72.58–215.62
Avg vol 30d2.2M
Short int10.2M · 8.7% float · 4.2d
Short vol64%
Last earningsAug 6, 2026
DataJan 2020–Aug 2026
Filing10-Q · Aug 5
Up next
Next earnings call
Nov 9, 2026
Est · unconfirmed
· in 10 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 5, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Weak
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 14.4 · calm
Equity put/call 0.62
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−12%
below
Price vs 50-day avg
+6%
above
RSI (14)
57
neutral
MACD trend
Positive
52-week position
45%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+17%
trailing
6-month return
−19%
trailing
YTD return
−3%
this year
Relative strength
−32%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $130 › 200d $156 — 200d above 50d
Institutional flow
Distributing
-5% holders QoQ · +128 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
8.67% of float · ▼ -8.5% MoM · 4.2 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
952 holders — mid 3-yr range
Squeeze score
59
elevated · 0–100
Fundamentals
Revenue growth
−4%
Y/Y
Gross margin
13%
expanding
EPS growth
+49%
Y/Y
Free cash flow
$692.5M
Balance sheet
$3.6B
net debt
Quant / Vol
risk profile
Volatility
59%
annualized · 1-yr
Max drawdown
−48%
past year
ATR
4.1%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed Aug 5, 2026
Capital expenditures
· FY 2026E
$500M
Specialties net sales
· FY 2026E
$1.4B – $1.6B
Prior guidance
period ended
· from the 8-K filed Nov 5, 2025
Capital expenditures
· FY 2025E
$600M
Depreciation and amortization
· FY 2025E
$630M – $670M
Interest and financing expenses
· FY 2025E
$180M – $210M
Free cash flow
· FY 2025E
$300M – $400M
Guided vs delivered
· last 2 settled
Total company net sales
2023
guided $9.5B – $9.8B
$9.62B
In line
Total company net sales
2022
guided $7.1B – $7.5B
$7.32B
In line
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−12%
Bearish
Price vs 50-day avg
+6%
Bullish
RSI (14)
57
Neutral
MACD trend
Positive
Bullish
52-week position
45%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $130 › 200d $156 — 200d above 50d
Institutional flow
Distributing
-5% holders QoQ · +128 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
8.67% of float · ▼ -8.5% MoM · 4.2 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
952 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $73
Now $137 · 45%
Range high $216
vs 200-day avg -12%
vs 50-day avg +6%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | $1.52B | Six Months Ended June 30, 2026 | — |
|
|
|||
| Adjusted EBITDA margin non-GAAP | 2% | Three Months Ended June 30, 2026 filing | — |
|
|
|||
| Avg. Realized Price ($/kg LCE) | $19.53 | Q2 2026 | — |
| Consolidated Leverage Ratio non-GAAP | 0.5 | Twelve Months Ended June 30, 2026 | — |
| Consolidated Windfield-Adjusted EBITDA non-GAAP | $2.03B | Twelve Months Ended June 30, 2026 | — |
| Consolidated Windfield-Adjusted Funded Net Debt non-GAAP | $996.13M | Twelve Months Ended June 30, 2026 | — |
| Corporate and all other adjusted EBITDA non-GAAP | $16.92M | Three Months Ended June 30, 2026 filing | — |
| Free cash flow non-GAAP | $638M | Q2 2026 | — |
|
|
|||
| Operating cash flow conversion non-GAAP | 83% | Q2 2026 | — |
| Sales Volume (kT LCE) | 65K | Q2 2026 | — |
| Total segment adjusted EBITDA non-GAAP | $841.18M | Three Months Ended June 30, 2026 filing | — |
| Adjusted diluted loss per share attributable to common shareholders non-GAAP | -$0.53 | Q4 2025 | — |
GAAP → non-GAAP reconciliationGAAP Diluted loss per share attributable to common shareholders -$3.87
+$0.15 Non-operating pension and OPEB items
+$3.19 Non-recurring and other unusual items
= Adjusted diluted loss per share attributable to common shareholders -$0.53
|
|||
| Adjusted effective income tax rate non-GAAP | -131.1% | Year Ended December 31, 2025 | — |
| Adjusted weighted-average common shares outstanding – diluted non-GAAP | 117.66M | Year Ended December 31, 2025 | — |
| Capital expenditures | $590M | Year Ended December 31, 2025 | — |
| Cash from operations | $1.3B | Year Ended December 31, 2025 | — |
| Cost and productivity improvements | $450M | full year 2025 | — |
| EBITDA non-GAAP | $512.58M | Year Ended December 31, 2025 | — |
| Energy Storage adjusted EBITDA non-GAAP | $167.1M | Q4 2025 | — |
| Estimated liquidity | $3.2B | As of December 31, 2025 | — |
| Ketjen Adjusted EBITDA non-GAAP | $49.7M | Q4 2025 | — |
| Net debt to adjusted EBITDA ratio non-GAAP | 2 | As of December 31, 2025 | — |
| Specialties Adjusted EBITDA non-GAAP | $68.6M | Q4 2025 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Specialty Chemicals — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ALB
this stock
Albemarle Corp
|
$16.21B | -2.9% | -4.4% | — | 8.7% |
|
LIN
Linde PLC
|
$223.74B | +14.8% | +3.0% | 31.3 | 1.1% |
|
AIQUF
L Air Liquide SA /Fi
|
$126.15B | +5.6% | — | — | 0.0% |
|
SHW
Sherwin Williams Co
|
$83.55B | +6.4% | +2.1% | 31.8 | 2.6% |
|
ECL
Ecolab Inc.
|
$80.15B | +9.2% | +2.2% | 38.4 | 1.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ALB | -4.1% | +16.8% | -19.0% | +16.8% | -2.9% |
| SPY | +0.5% | +3.0% | +13.4% | +3.0% | +12.8% |
| vs SPY | -4.6% | +13.8% | -32.4% | +13.8% | -15.7% |
Capital returns
Latest dividend
$0.405
/ share · ex Jun 12, 2026
Declared · upcoming
$0.41
/ share · ex Sep 11, 2026
Paid (TTM)
$1.62
/ share · 4 payouts
Dividend yield (TTM, derived)
1.18%
Buyback program
· as of Dec 31, 2025
Authorized
shares 15.00M
Spent (derived)
shares 7.60M
Remaining
shares 7.40M
Spent
Remaining
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.
Key facts
CIK
915913
CUSIP
012653101
13F (30d)
691 filings
668 filers
Visit website
Investor relations